Jeff Shaner, Chief Executive Officer of Aveanna Healthcare Holdings, Inc. (NASDAQ:AVAH), filed a Form 4 on August 24, 2026, disclosing the sale of 90,000 shares of common stock on August 20, 2026, as part of an underwritten secondary offering.

Key Highlights

  • Transaction: Chief Executive Officer Jeff Shaner disposed of 90,000 shares of Aveanna Healthcare common stock on August 20, 2026.
  • Sale price: Shares were sold at $11.5 per share.
  • Secondary offering context: The shares were sold as part of an underwritten secondary offering of 15,000,000 shares of the issuer's common stock, which closed on August 24, 2026.
  • Remaining ownership: Following the transaction, Shaner directly beneficially owns 2,561,972 shares.
  • ESPP shares included: The post-transaction total includes 1,080 shares acquired under the registrant's Employee Stock Purchase Plan in June 2026.
  • Transaction code: The sale was coded "S" (open-market or secondary sale) under direct ownership.

CEO Jeff Shaner's Share Disposal in Aveanna's August 2026 Secondary Offering

According to the filing, Jeff Shaner, serving as Chief Executive Officer of Aveanna Healthcare Holdings, Inc., sold 90,000 shares of the company's common stock, par value $0.01 per share, at a price of $11.5 per share on August 20, 2026. The filing indicates the transaction code was "S," reflecting a disposition of directly held shares.

The filing discloses that the shares sold by the reporting person "were part of an underwritten secondary offering of 15,000,000 shares of the Issuer's common stock which closed on August 24, 2026." The Form 4 was filed on August 24, 2026, signed by Jonathan Beckler as Attorney-in-Fact on behalf of Shaner.

Following the reported transaction, Shaner's direct beneficial ownership stands at 2,561,972 shares, according to the filing. The filing notes that this total includes 1,080 shares acquired under the registrant's Employee Stock Purchase Plan in June 2026. No derivative securities transactions were reported. The filing does not indicate that any transaction was made pursuant to a Rule 10b5-1 plan.

What Was Disclosed

The Form 4 discloses a single disposition of 90,000 shares of Aveanna Healthcare common stock by CEO Jeff Shaner at $11.5 per share on August 20, 2026, conducted through an underwritten secondary offering, leaving him with direct beneficial ownership of 2,561,972 shares.